Approximately 55.82 million yuan! Yidu Tech (02158.HK) wins the bid for the Phase III clinical trial project of recombinant human nerve growth factor (SMR001) eye drops.

According to the WiseFinancial APP, Yidu Tech (02158.HK) announced that its affiliated company Tianjin Happy Life Technology Co., Ltd. recently won the bid for the reorganization of the Phase III clinical research project of Human Nerve Growth Factor (SMR001) eye drops for Shandong Yandu Biotechnology Co., Ltd. The total amount of the project is approximately RMB 55.82 million.